Newswise — Lloyd Paul Aiello, M.D., Ph.D., a leader in the field of academic ophthalmology, recently was named Director of Joslin Diabetes Center's Beetham Eye Institute. Dr. Aiello is also the Head of Joslin's Section on Eye Research and is an Associate Professor of Ophthalmology at Harvard Medical School. His appointment in May, after two years as the Associate Director, continues the tradition of outstanding leadership at Joslin's Beetham Eye Institute.
The former director, Lloyd M. Aiello, M.D., is now Founding Director and continues to provide exceptional patient and staff education. He also continues his work as a principal investigator in the Section on Eye Research at Joslin and an Associate Clinical Professor of Ophthalmology at Harvard Medical School. Under his leadership, the Beetham Eye Institute grew and developed into one of the most highly regarded centers for treating diabetic eye disease in the world.
Lloyd Paul Aiello, M.D., Ph.D., a third-generation ophthalmologist, received his undergraduate degree from the University of Pennsylvania and received both his M.D./Ph.D. degrees at Boston University School of Medicine. Dr. Aiello joined the staff at Joslin in 1994 and has since been an integral part of the Beetham Eye Institute. Dr. Aiello's research focuses on eliminating vision loss resulting from diabetic retinopathy, one of the complications of diabetes. Dr. Aiello is active in numerous professional organizations. He has served as Chair for two Medical Science Review Committees of the Juvenile Diabetes Research Foundation, the American Diabetes Association Lions SightFirst Diabetic Retinopathy Research Program and the National Institutes of Health-sponsored Diabetic Retinopathy Clinical Research Network.
"We are honored to have Dr. Lloyd Paul Aiello lead the Beetham Eye Institute," says C. Ronald Kahn, M.D., President and Director of Joslin Diabetes Center and the Mary K. Iacocca Professor at Harvard Medical School. "His expertise in the field of eye research and care ensures Joslin's continued leadership in preventing, diagnosing and treating eye disease in people with diabetes."
Diabetes is the leading cause of blindness in people aged 20 to 74 in the United States. Clinicians at the Beetham Eye Institute, world leaders in the field, provide total eye care services for preventing, diagnosing and treating diabetes-related eye problems. The technology used by the Joslin Vision Network (JVN) TM was established at the Beetham Eye Institute and is the only diagnostic retinal evaluation service offering patients a pain-free and non-dilated diabetic eye evaluation that has been validated against dilated eye exams by retinal specialists. The JVN is already in use at more than 35 federal health care sites in 15 states, as well as the Joslin Diabetes Center Affiliate in Bahrain. Most recently, Joslin opened the first JVN affiliate at Koch Eye Associates in Warwick, RI.
"The Beetham Eye Institute not only excels in providing state-of-the-art eye care, but also offers an unparalleled opportunity to identify, evaluate and implement new therapies to prevent vision loss in people with diabetes. It is a privilege to lead such a distinguished and talented group during this exciting period," says Dr. Lloyd Paul Aiello, who resides in Belmont, MA.
About Beetham Eye Institute
Joslin's Eye Institute is named after William P. Beetham, M.D., who together with Lloyd M. Aiello pioneered the use of a unique technique in laser surgery for diabetic eye disease called pan-retinal photocoagulation. This technique has helped thousands of people with diabetes reduce the risk of vision loss. Today, in addition to laser surgery, which is recognized as vital to treatment, the ophthalmologists of the Eye Institute offer many surgical interventions including cataract, glaucoma, oculo-plastics and vitreo-retinal procedures. The Beetham Eye Institute continues to undertake a wide range of research programs to develop better means of identifying the causes of diabetic eye disease and to devise treatments to lessen the risks of visual loss.
About Joslin Diabetes Center
Joslin Diabetes Center, dedicated to conquering diabetes in all of its forms, is the global leader in diabetes research, care and education. Founded in 1898, Joslin is an independent nonprofit institution affiliated with Harvard Medical School. Joslin research is a team of more than 300 people at the forefront of discovery aimed at preventing and curing diabetes. Joslin Clinic, affiliated with Beth Israel Deaconess Medical Center in Boston, the nationwide network of Joslin Affiliated Programs, and the hundreds of Joslin educational programs offered each year for clinicians, researchers and patients, enable Joslin to develop, implement and share innovations that immeasurably improve the lives of people with diabetes. As a nonprofit, Joslin benefits from the generosity of donors in advancing its mission. For more information on Joslin, call 1-800-JOSLIN-1 or visit http://www.joslin.org.
RSS